Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Hisse Senetlerindeki Sıralama #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Hisse Fiyatı
$3.83
Piyasa Değeri
$464.45M
Değişim (1 gün)
-1.63%
Değişim (1 yıl)
17.17%
Ülke
TW
Ticaret Gongwin Biopharm Holdings Co., Ltd. (6617)

Kategori

Gongwin Biopharm Holdings Co., Ltd. (6617) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $3.43 - 2026-08-01

Gün sonu en düşük fiyat: $2.71 - 2017-02-01
Gongwin Biopharm Holdings Co., Ltd. için hisse fiyatı geçmişi: 2017 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU